Physician profile
Reshma Modha Amin
NPI 1144455726
$2,075.20
in general payments reported to CMS, 2019-2025
18 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $14.27 · 2021: $239 · 2022: $677 · 2023: $218 · 2024: $255 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $503.58 | 2021-2025 | Tryptyr |
| Johnson & Johnson Vision Care, INC. | $280.29 | 2019-2025 | Acuvue |
| Coopervision INC. | $251.33 | 2020-2024 | Biofinity Contact Lens |
| Bausch & Lomb Americas INC. | $189.49 | 2022-2025 | Infuse |
| Sight Sciences, INC. | $164.10 | 2022-2023 | Tearcare System |
| Biotissue Holdings INC. | $147.43 | 2022-2025 | |
| Optos, INC. | $127.72 | 2019 | |
| Allergan, INC. | $105.01 | 2021-2022 | |
| Heru, INC. | $79.08 | 2022 | |
| Sun Pharmaceutical Industries INC. | $49.74 | 2021-2025 | |
| Abbvie INC. | $41.05 | 2022 | |
| Dompe US, INC. | $32.04 | 2024 | Oxervate |
| Glaukos Corporation | $23.03 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.58 | 2019 | |
| Harrow Eye, LLC | $17.27 | 2024 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $15.06 | 2024 | Acthar |
| Tarsus Pharmaceuticals, INC. | $14.52 | 2025 | Xdemvy |
| Lkc Technologies, INC. | $13.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reshma Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.